SB
Sino Biopharmaceutical Limited
SBHMY · OTC
$14.54 -2.85% (-$0.43)
1M +21.07%
Market Cap ¥86.6B
P/E Ratio 37.99x
Div. Yield 2.11%
ROE 7.16%
Bulios Fair Price
$20.57
41.4% upside
Trenutna cena
$14.54
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SBHMY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
62 /100
Fair P/E 37.99x
EV/EBITDA 12.25x
P/FCF 11.41x
Growth
53 /100
Stable EPS growth 2.70%
Rev. growth 5.97%
Book val. growth 1.05%
Profitability
87 /100
Strong Gross margin 82.07%
Net margin 7.36%
FCF margin 24.51%
Quality
39 /100
Average ROIC 8.65%
ROE 7.16%
Asset turnover 0.41x
Debt
84 /100
Low Debt/Equity 0.52x
Current ratio 1.37x
Net debt/EBITDA 1.12x
Stability
75 /100
Stable Beta 0.61x
Rev. volatility 4.88%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SBHMY
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
S. Y. Tse
Employees
21,435
Headquarters
Hong Kong